Progress in Neuro-Psychopharmacology
Special topic: Mechanisms of anorexia induced by drugsBehavioural analysis of feeding: Implications for the pharmacological manipulation of food intake in animals and man
References (25)
- et al.
Pharmacological approaches to the understanding of obesity
- et al.
Weight changes with schizophrenic psychosis and psychotropic drug therapy
Psychosom
(1970) Free feeding in normal and ‘recovered lateral’ rats monitored by a pellet-detecting eatometer
Physiol. Behav.
(1970)- et al.
Measurement of appetite disturbances in psychiatric disorders
J. Psychiat. Res.
(1975) - et al.
On the selective inhibition of serotonin uptake in vivo by ORG 6582
Eur. J. Pharmacol.
(1976) - et al.
Failure of tryptophan load-induced increases in brain serotonin to alter food intake in the rat
Life Sci.
(1978) - et al.
Combined reserpine-chlorpromazine in the treatment of disturbed psychotics
Arch. Neurol. Psychiat.
(1965) Strategies and tactics in the use of anti-obesity drugs
Lancet
(1976)Is there a role for serotonin (5-hydroxytryptamine) in feeding?
Int. J. Obesity
(1977)Serotonin and Feeding
Pharmacological manipulation of feeding: possible influences of serotonin and dopamine on food intake
Pharmacology of Food and Water Intake
Cited by (19)
Selective serotonin 5-HT<inf>2C</inf> receptor activation suppresses the reinforcing efficacy of cocaine and sucrose but differentially affects the incentive-salience value of cocaine- vs. sucrose-associated cues
2011, NeuropharmacologyCitation Excerpt :Studies over the last 20 years have identified cellular and behavioral mechanisms of these appetitive processes to include dopamine, glutamate, and their intracellular signaling webs in the limbic–corticostriatal–hypothalamic circuit (Kelley, 2004). Serotonin (5-HT) is additionally important in the control over the affective and motivational aspects of palatable food and drug reward, which has been described to occur at the level of satiety (Hewitt et al., 2002; Lyness et al., 1980; Blundell et al., 1980) as well as palatability or reinforcing efficacy (Wogar et al., 1991). In particular, there is a growing literature based upon genetic and pharmacological manipulations that the serotonin 5-HT2C receptor (5-HT2CR) signaling regulates such neurobehavioral processes which may underlie important chronic health maladies including obesity, eating disorders and drug addiction (Halford et al., 2010; Bubar and Cunningham, 2008; Steiger, 2004).
Metergoline antagonizes fluoxetine-induced suppression of food intake but not changes in the behavioural satiety sequence
1996, Pharmacology Biochemistry and BehaviorFood and Water Intake
1994, Handbook of Behavioral NeuroscienceExperimental manipulations of eating: Advances in animal models for studying anorectic agents
1987, Pharmacology and TherapeuticsNeuropharmacology of drugs affecting food intake
1987, Pharmacology and TherapeuticsHypothalamic serotonin in the control of meal patterns and macronutrient selection
1986, Brain Research Bulletin